{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:07:10Z","timestamp":1785895630130,"version":"3.56.0"},"reference-count":70,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14326","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T12:56:02Z","timestamp":1709556962000},"source":"Crossref","is-referenced-by-count":3,"title":["Prognostic biomarker HIF1\u03b1 and its correlation with immune infiltration in gliomas"],"prefix":"10.3892","volume":"27","author":[{"given":"Zihan","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunliang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"key20240412091839_b1-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S1474-4422(18)30468-X","article-title":"GBD 2016 Brain and Other CNS Cancer Collaborators: Global, regional, and national burden of brain and other CNS cancer, 1990\u20132016: A systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"key20240412091839_b2-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"15017","DOI":"10.1038\/nrdp.2015.17","article-title":"Glioma","volume":"1","author":"Weller","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"key20240412091839_b3-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/jnnp-2020-325334","article-title":"Advances in the management of glioblastoma","volume":"92","author":"Ma","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20240412091839_b4-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"key20240412091839_b5-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","article-title":"Clinical practice guidelines for the management of adult diffuse gliomas","volume":"499","author":"Jiang","year":"2021","journal-title":"Cancer Lett"},{"key":"key20240412091839_b6-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"iii93","DOI":"10.1093\/annonc\/mdu050","article-title":"ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Stupp","year":"2014","journal-title":"Ann Oncol"},{"key":"key20240412091839_b7-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"key20240412091839_b8-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1002\/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T","article-title":"Grading of astrocytomas. A simple and reproducible method","volume":"62","author":"Daumas-Duport","year":"1988","journal-title":"Cancer"},{"key":"key20240412091839_b9-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key20240412091839_b10-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N Engl J Med"},{"key":"key20240412091839_b11-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-012-0798-3","article-title":"Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery","volume":"108","author":"Stummer","year":"2012","journal-title":"J Neurooncol"},{"key":"key20240412091839_b12-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-bioeng-071813-105259","article-title":"The role of mechanical forces in tumor growth and therapy","volume":"16","author":"Jain","year":"2014","journal-title":"Annu Rev Biomed Eng"},{"key":"key20240412091839_b13-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11060-013-1103-9","article-title":"Management and survival rates in patients with glioma in China (2004\u20132010): A retrospective study from a single-institution","volume":"113","author":"Yang","year":"2013","journal-title":"J Neurooncol"},{"key":"key20240412091839_b14-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13578-023-01171-8","article-title":"Predictive and prognostic biomarkers of bone metastasis in breast cancer: Current status and future directions","volume":"13","author":"Wang","year":"2023","journal-title":"Cell Biosci"},{"key":"key20240412091839_b15-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/emboj.2012.125","article-title":"The updated biology of hypoxia-inducible factor","volume":"31","author":"Greer","year":"2012","journal-title":"EMBO J"},{"key":"key20240412091839_b16-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/BJ20081055","article-title":"Regulation of gene expression by hypoxia","volume":"414","author":"Kenneth","year":"2008","journal-title":"Biochem J"},{"key":"key20240412091839_b17-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20240412091839_b18-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1101\/gad.12.2.149","article-title":"Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha","volume":"12","author":"Iyer","year":"1998","journal-title":"Genes Dev"},{"key":"key20240412091839_b19-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: Sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20240412091839_b20-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"key20240412091839_b21-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"key20240412091839_b22-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tig.2008.10.012","article-title":"Co-evolution of tumor cells and their microenvironment","volume":"25","author":"Polyak","year":"2009","journal-title":"Trends Genet"},{"key":"key20240412091839_b23-ol-27-5-14326","first-page":"1621","article-title":"Tumor-associated macrophage\/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1","volume":"34","author":"Okada","year":"2009","journal-title":"Int J Oncol"},{"key":"key20240412091839_b24-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.10679","article-title":"Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas","volume":"54","author":"Platten","year":"2003","journal-title":"Ann Neurol"},{"key":"key20240412091839_b25-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.3390\/ijms22115518","article-title":"The acidic brain-glycolytic switch in the microenvironment of malignant glioma","volume":"22","author":"Reuss","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20240412091839_b26-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"key":"key20240412091839_b27-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"key20240412091839_b28-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"key20240412091839_b29-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"key20240412091839_b30-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20240412091839_b31-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"key20240412091839_b32-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"key20240412091839_b33-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"key":"key20240412091839_b34-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"key20240412091839_b35-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models: Users' guides to the medical literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA"},{"key":"key20240412091839_b36-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20240412091839_b37-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"e63777","DOI":"10.1371\/journal.pone.0063777","article-title":"Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-\u03b21 in gastric cancer","volume":"8","author":"Deng","year":"2013","journal-title":"PLoS One"},{"key":"key20240412091839_b38-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41419-022-05389-1","article-title":"PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism","volume":"13","author":"Liao","year":"2022","journal-title":"Cell Death Dis"},{"key":"key20240412091839_b39-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13045-021-01102-5","article-title":"The relationship between expression of PD-L1 and HIF-1\u03b1 in glioma cells under hypoxia","volume":"14","author":"Ding","year":"2021","journal-title":"J Hematol Oncol"},{"key":"key20240412091839_b40-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1038\/s41598-017-06086-2","article-title":"HIF1\u03b1 regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"key20240412091839_b41-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20240412091839_b42-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: Significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"key20240412091839_b43-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/path.1708","article-title":"Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology","volume":"205","author":"Tachibana","year":"2005","journal-title":"J Pathol"},{"key":"key20240412091839_b44-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3892\/ol.2021.12736","article-title":"Analysis of the association between KIN17 expression and the clinical features\/prognosis of epithelial ovarian cancer, and the effects of KIN17 in SKOV3 cells","volume":"21","author":"Chen","year":"2021","journal-title":"Oncol Lett"},{"key":"key20240412091839_b45-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1056\/NEJMoa1716078","article-title":"Neoadjuvant PD-1 blockade in resectable lung cancer","volume":"378","author":"Forde","year":"2018","journal-title":"N Engl J Med"},{"key":"key20240412091839_b46-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S2213-2600(18)30500-9","article-title":"Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study","volume":"7","author":"Leighl","year":"2019","journal-title":"Lancet Respir Med"},{"key":"key20240412091839_b47-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/S0140-6736(19)30723-8","article-title":"Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): A multicentre, open-label, phase 3, randomised controlled trial","volume":"393","author":"Rini","year":"2019","journal-title":"Lancet"},{"key":"key20240412091839_b48-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"key20240412091839_b49-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"key20240412091839_b50-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ni.2714","article-title":"Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen","volume":"14","author":"Doedens","year":"2013","journal-title":"Nat Immunol"},{"key":"key20240412091839_b51-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm.3868","article-title":"Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha","volume":"21","author":"Mascanfroni","year":"2015","journal-title":"Nat Med"},{"key":"key20240412091839_b52-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ccell.2021.05.016","article-title":"Innate immune cells in the tumor microenvironment","volume":"39","author":"Li","year":"2021","journal-title":"Cancer Cell"},{"key":"key20240412091839_b53-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"key20240412091839_b54-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1136\/gutjnl-2021-325137","article-title":"Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT","volume":"71","author":"Tian","year":"2022","journal-title":"Gut"},{"key":"key20240412091839_b55-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1158\/1078-0432.CCR-13-1279","article-title":"Neutrophils promote the malignant glioma phenotype through S100A4","volume":"20","author":"Liang","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20240412091839_b56-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"key20240412091839_b57-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/leu.2014.105","article-title":"Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia","volume":"28","author":"Saulep-Easton","year":"2014","journal-title":"Leukemia"},{"key":"key20240412091839_b58-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: An update","volume":"196","author":"Michel","year":"2016","journal-title":"J Immunol"},{"key":"key20240412091839_b59-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.smim.2014.01.006","article-title":"Development of human natural killer cells and other innate lymphoid cells","volume":"26","author":"Montaldo","year":"2014","journal-title":"Semin Immunol"},{"key":"key20240412091839_b60-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrclinonc.2016.168","article-title":"PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas","volume":"14","author":"Goodman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"key20240412091839_b61-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1084\/jem.183.6.2533","article-title":"CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells","volume":"183","author":"Krummel","year":"1996","journal-title":"J Exp Med"},{"key":"key20240412091839_b62-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"key20240412091839_b63-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1001\/jamaoncol.2017.1588","article-title":"Nivolumab for patients with advanced melanoma treated beyond progression: Analysis of 2 phase 3 clinical trials","volume":"3","author":"Long","year":"2017","journal-title":"JAMA Oncol"},{"key":"key20240412091839_b64-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2015.04.003","article-title":"Translational activation of HIF1\u03b1 by YB-1 promotes sarcoma metastasis","volume":"27","author":"El-Naggar","year":"2015","journal-title":"Cancer Cell"},{"key":"key20240412091839_b65-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1631\/jzus.B1400221","article-title":"Hypoxia-inducible factor 1 and breast cancer metastasis","volume":"16","author":"Liu","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"key":"key20240412091839_b66-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1038\/s41467-021-24703-7","article-title":"TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer","volume":"12","author":"Xu","year":"2021","journal-title":"Nat Commun"},{"key":"key20240412091839_b67-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10456-020-09744-8","article-title":"RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway","volume":"24","author":"Qiao","year":"2021","journal-title":"Angiogenesis"},{"key":"key20240412091839_b68-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1369\/jhc.4A6521.2005","article-title":"Does vasculogenic mimicry exist in astrocytoma?","volume":"53","author":"Yue","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"key20240412091839_b69-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3892\/or.2014.3454","article-title":"Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1alpha","volume":"32","author":"Huang","year":"2014","journal-title":"Oncol Rep"},{"key":"key20240412091839_b70-ol-27-5-14326","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3892\/etm.2014.2162","article-title":"Inhibitory effects of B-cell lymphoma 2 on the vasculogenic mimicry of hypoxic human glioma cells","volume":"9","author":"Li","year":"2015","journal-title":"Exp Ther Med"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T06:18:44Z","timestamp":1712902724000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14326","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"article-number":"193"}}